Corpus Intelligence IC Memo — CANYON VISTA MEDICAL CENTER 2026-04-26 04:05 UTC
IC Memo — CANYON VISTA MEDICAL CENTER
Investment Committee Memorandum | AZ | 74 beds | Grade C | EBITDA uplift $9.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CANYON VISTA MEDICAL CENTER

CCN 030043 | COCHISE, AZ | 74 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CANYON VISTA MEDICAL CENTER is a 74-bed suburban community hospital in COCHISE, AZ with $132.6M in net patient revenue and a 1.9% operating margin. The hospital serves a payer mix of 35.6% Medicare, 16.3% Medicaid, and 48.0% commercial.

Thesis: Turnaround. Our ML models identify $9.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.9% to 9.3% (+736bps).

Net Revenue HCRIS$132.6M
Current EBITDA COMPUTED$2.6M
Operating Margin COMPUTED1.9%
Occupancy HCRIS53.9%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS22.9%
Distress Probability ML48.9%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
54
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 1.9% places it above the state median. Among 54 size-comparable peers (37-148 beds), the median margin is 2.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (37-148), prioritizing same-state peers. 54 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CANYON VISTA MEDICAL CENTER (Target)AZ74$132.6M1.9%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
BANNER UNIVERSITY MED CENTER SAZ132$190.9M-16.3%
HONORHEALTH SCOTTSDALE THOMPSOAZ120$187.9M-1.6%
VERDE VALLEY MEDICAL CENTERAZ87$172.5M4.3%
BANNER HEART HOSPITALAZ108$162.2M17.4%
BANNER CASA GRANDE MEDICAL CENAZ141$151.2M-6.3%
NORTHWEST MEDICAL CENTER ORO VAZ96$145.8M10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$85K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.6M
A/R Days Reduction
$1.6M
Clean Claim Rate
$85K
Total EBITDA Uplift$9.8M
Current EBITDA$2.6M
+ RCM Uplift+$9.8M
Pro Forma EBITDA$12.3M
Current Margin1.9%
Pro Forma Margin9.3%
WC Released (1x)$5.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.9M$114.5M29.16x96.3%
Base (11x exit)10.0x11.0x$3.9M$127.2M32.41x100.5%
Bull Case9.0x11.0x$3.5M$160.7M45.49x114.6%
Bull (12x exit)9.0x12.0x$3.5M$176.3M49.92x118.6%
Bear Case11.0x10.0x$4.3M$64.4M14.91x71.7%
Bear (11x exit)11.0x11.0x$4.3M$72.2M16.73x75.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 54 hospitals with 37-148 beds
  • Same-state prioritization (n=55)
  • Comp margins: P25=-10.9% / P50=2.5% / P75=10.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.